ASEAN Pharmaceutical Venture Capital Fund
Explore how ASEAN Connections bridges the gap between visionary capital and life-saving pharmaceutical innovation.
Strategic Growth Advantages
Why the most ambitious biotech founders partner with ASEAN Connections.
Regulatory Navigation
We provide direct conduits to health ministries in Bangkok, Hanoi, and Jakarta. We eliminate the guesswork from regional pharmaceutical compliance.
Cross-Border Scaling
Move your product from a Singaporean lab to Vietnamese manufacturing seamlessly. We handle the logistics of regional expansion.
Patient Access Networks
Immediate access to a network of 150+ clinical trial sites across the ASEAN bloc, accelerating your Phase II and III trials.
Specialized Bio-Capital
Our funding isn't generic. We provide milestone-based capital specifically tailored to the long timelines of drug development.
Our track record is defined by the success of the biotech firms we have scaled across the region. By combining deep local knowledge with global capital, we consistently outperform standard market benchmarks. This proven approach ensures that our partners gain a sustainable competitive edge in the pharmaceutical sector.
Our Ecosystem Partners
The Power of Synergy
Our network of strategic alliances opens doors to exclusive regulatory insights and untapped markets. These partnerships reduce entry barriers for every pharmaceutical project we fund.
By leveraging collective expertise, we accelerate the path from laboratory to patient. ASEAN Connections transforms individual capital into systemic regional impact.
Frequently Asked Questions
Everything you need to know about our investment process.
Which stages of development do you fund?
We primarily focus on Seed to Series B. We look for companies that have completed initial proof-of-concept and are moving toward clinical trials.
Do you invest in medical devices or just drugs?
While our core focus is pharmacology, we invest in high-impact medical devices and diagnostic tools that integrate with pharmaceutical treatments.
What are your geographic requirements?
The company must have a primary operational hub or a clear expansion plan within the ASEAN member states, particularly Singapore, Thailand, or Vietnam.
How long is your typical investment horizon?
Pharmaceutical development is a marathon. We typically plan for a 5 to 10-year horizon before seeking an exit through IPO or acquisition.
Do you provide non-financial support?
Yes. We provide legal assistance for patent filing in multiple ASEAN jurisdictions and introduce founders to strategic manufacturing partners.
While these answers cover the basics, every venture capital opportunity has its own unique nuances. We invite you to schedule a private consultation to discuss specific regulatory frameworks or portfolio goals. Our experts provide tailored insights that go far beyond general inquiries.
Our Investment Process
From first contact to commercial launch.
Initial Screening
We review your pitch deck and scientific data to ensure alignment with our therapeutic focus.
Technical Due Diligence
Our team of PhDs and MDs validates your research and assesses the scalability of the technology.
Investment Committee
Final review of the business model, team capability, and projected market impact in the ASEAN region.
Funding & Integration
Capital is deployed, and you are integrated into our network of mentors and regulatory experts.
Beyond the Process
Once the final step is complete, our dedicated team begins the active management phase. We ensure your venture integrates seamlessly into the regional healthcare ecosystem.
Continuous monitoring and strategic adjustments follow to maximize ROI. ASEAN Connections remains your partner through every growth milestone.
Inside Our Innovation Hubs
These images capture the real-world impact of our investments in regional medical infrastructure.
Ready to Transform Global Health?
Join a portfolio of innovators redefining medicine in Southeast Asia. Submit your pitch deck today.
Submit Pitch DeckYour investment security is our highest priority throughout the entire partnership. We operate with full transparency and adhere to the strictest international compliance standards. Join a community where professional integrity drives pharmaceutical innovation across Southeast Asia.